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Purpose: The main purpose was to investigate the differences of the esophageal motion (EM) and
the internal target volume (ITV) margins for the esophagus between clinical T1-T3 (cT1-T3) and
cT4 cases, using 4-dimensional computed tomography. A secondary purpose was to assess the
metastatic lymph nodal motion (NM) and the ITV margins for lymph nodes (LNs) using the
datasets of patients with nodal involvement pathologically deﬁned.
Methods and materials: We analyzed patients with thoracic esophageal cancer consecutively
treated with deﬁnitive chemoradiation, measuring the EM and the ITV margins in the left-right,
anteroposterior, and superoinferior directions. All esophageal contours were divided at the carina.
The EM and NM were measured from the displacement of the centroid point between 0% images
(at the end of inhalation) and 50% images (at the end of exhalation). The ITV margins were deﬁned
as the maximum distance in each direction from the clinical target volume at the 4-dimensional
computed tomography average images to the intersection of the clinical target volume at the 0%
and 50% images of complete coverage in each patient.
Results: The EM below the carina in cT4 was signiﬁcantly smaller than that in cT1-T2 in all
directions (P < .01) and than that in cT3 in all directions (left-right: PZ .03, anteroposterior and
superoinferior: P < .01). The EM in the case of a cT4 tumor located below the carina was smaller
than that in the case of cT4 tumor located above the carina. The NM of abdominal-LNs was much
larger than that of cervicothoracic-LNs and the EM below the carina. These tendencies were similar
in the ITV measurements.
Conclusions: The EM and the ITV margins in cT4 were signiﬁcantly smaller than those in cT1-T3.
The NM and the ITV margins of abdominal LNs were much larger than those of cervicothoracic
LNs and the esophagus. In clinical radiation therapy planning for esophageal cancer, we should
take cT stage into consideration.Conﬂicts of interest: None.
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In chemoradiation therapy (CRT) for esophageal can-
cer, the accurate deﬁnition of radiation treatment (RT)
ﬁelds is crucial because the esophagus is a typical intra-
thoracic mobile organ because of the physiological motion
caused by respiration, cardiac activity, and esophageal
peristalsis.1 CRT plays an important role in deﬁnitive and
preoperative treatments for esophageal cancer.2,3 Unnec-
essarily large radiation therapy (RT) ﬁelds increase the risk
of radiation pneumonitis and pericarditis in esophageal
cancer treated with CRT.4 When needlessly large margins
are added to the clinical target volume (CTV) for patients
with large primary tumor such as in clinical T4 (cT4)
cases, high-grade radiation toxicities may be induced by
CRT. However, a deﬁnition of the minimum necessary
margins for esophageal cancer treated with CRT has not
been established.
In RT planning for esophageal cancer, the CTV is often
deﬁned as esophageal tumor and the partial esophagus
with a possible subclinical spread, but these are not clearly
distinguished from each other by gastroesophageal
endoscopy, ﬂuorodeoxyglucose (FDG)-positron emission
tomography (PET)/computed tomography (CT), and other
image inspections. The tendencies of esophageal cancer
for submucosal skip metastases or multicentric focal dis-
ease result from tumor spread to the intramural lymphatic
plexuses, which is lacking in the superﬁcial mucosa.5 In
52% of a series of patients with advanced esophageal
cancer, the length of the primary esophageal tumor was>5
cm.2 In RT planning for esophageal cancer, the margins in
the superoinferior (SI) direction were often deﬁned as 5 cm
from primary tumor.2,6 The length of the RT ﬁelds is
frequently longer than at least 15 cm. The length of the
thoracic esophagus is approximately 22 cm as described in
the International Union Against Cancer classiﬁcation (6th
edition), and thus the length of the RT ﬁeld is commonly
more than one-half of the thoracic esophagus in many
locally advanced cases. For these reasons, we investigated
the characteristics of the esophageal motion (EM) and the
internal target volume (ITV) margins for the esophagus in
a ﬁeld that is sufﬁciently long. Cohen et al7 also evaluated
the inter-/intrafraction EM of esophageal cancer patients to
account for microscopic tumor spread and skip metastases.
The ITV is deﬁned as the CTV plus the ITV margins to
account for physiological motion induced by respiration
and cardiac activity.8 The RT ﬁelds are determined by the
planning target volume, which is deﬁned as the ITV plus
the setup margin.8 Image guided radiation therapy has
technically achieved minimization of the setup margin,
and thus the optimization of the ITV margin is animportant factor in the determination of the planning
target volume. Four-dimensional CT (4DCT) is one of the
most important techniques to determine the ITV margin
for RT planning.9 Several studies that reported on
esophageal tumor motion using 4DCT have been pub-
lished.10-16 In those studies, however, the inﬂuence of
esophageal tumor invasion was not discussed.
Patel et al11 recommended that different ITV margins
should be applied between esophageal tumor and lymph
nodes (LNs). Although they used the images of FDG-
PET/CT to diagnose metastatic LNs, the positive pre-
dictive value of FDG-PET/CT was approximately 60%.17
Because enlarged thoracic LNs may be induced by either
malignancy, infection, and/or inﬂammatory conditions,
we retrospectively analyzed the lymph nodal motion
(NM) using enlarged LNs that were pathologically
conﬁrmed by planned surgical resection performed within
a couple of months after CRT. Siewert et al18 summa-
rized the prevalence rates of 722 patients with LN
metastasis for both esophageal adenocarcinoma and
esophageal squamous cell carcinoma (ESCC). Their
analysis revealed that the rates of LN metastasis in stages
T3 and T4 were 74% and 100%, respectively, using a
database of 414 cases of ESCC. Therefore, the optical
information about physiological motion of the esophagus
and LNs are important to treat esophageal cancer. It is
also necessary to consider whether to set the ITV margins
to the esophagus and metastatic LNs individually.
Our hypothesis in the present study was that the
EMdespecially in stage cT4 casesdmay be smaller than
that in stage cT1-T3 cases because of the inﬂuence of tumor
invasion to the adjacent structures. The main purpose of
this study was thus to assess the EM and the ITV margins
for the esophagus according to cT stage and primary tumor
location. A secondary purpose was to assess the NM and
the ITV margins for metastatic LNs, because lymphatic
metastases are generally treated with CRT in locally
advanced esophageal cancer with or without elective
lymphatic irradiation. For the assessments of the NM and
the ITVmargins for LNs, we used the pretreatment datasets
of patients with nodal involvement pathologically deﬁned
after planned surgical resection following CRT.Methods and materials
Patients
All 4DCT datasets were acquired at pretreatment. For
the measurements of EM, we selected 33 patients with
pathologically conﬁrmed thoracic ESCC. For the
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astatic regional LNs that were pathologically conﬁrmed
by planned surgical resection performed within a mean of
5.1 weeks (range, 3.0-8.4 weeks) after CRT. All patients
were treated with concurrent CRT between November
2011 and April 2015 at our institute. The patient
characteristics are listed in Table 1. All patients were
diagnosed based on enhanced CT, esophagogas-
troduodenoscopy, contrast roentgenography, and FDG-
PET/CT. The depth of primary tumor invasion was
diagnosed using magnetic resonance imaging and/or
endoscopic ultrasound before treatment. Clinical TNM
classiﬁcation was deﬁned using the International Union
Against Cancer classiﬁcation, 6th edition. In the EM
measurements, cT4 stage was determined by the invasive
depth of primary tumor. This study was approved by the
institutional ethics board in November 2011.
4DCT scanning
The 4DCT scans were performed on all patients from
the laryngeal level to the celiac trunk level using an
Optima CT scanner (GE Medical Systems, Milwaukee,
WI). The 4DCT datasets were obtained at 2.5-mm sliceTable 1 Patient characteristics
Variable Esophageal
motion
Nodal
motion
Age (y), mean (range) 69.2 (59-82) 65.2 (46-82)
Gender (n)
Male 27 16
Female 6 4
Tumor stage (n)
T1 6 1
T2 2 0
T3 11 6
T4 14 13
Nodal stage (n)
N0 9 0
N1 24 20
Primary tumor length (cm)
Mean (range) 6.5 (2-15) NA
Primary tumor sites (n)
Upper thoracic 12 3
Middle thoracic 10 11
Lower thoracic 11 6
Duration between RT and
Op (weeks)
Mean (range) 5.1 (3.0-8.4)
Metastatic lymph nodal
area (n)
NA
Cervical and thoracic 11
Abdominal 9
Nodal invasion to adherent
structures (n)
1
NA, not applicable; Op, operation; RT, radiation therapy.thickness under free breathing. All patients were scanned
in the supine position with both arms laid parallel to the
body. The Varian Real-time Position Management system
(Varian Medical System, Palo Alto, CA) was used to
monitor respiratory signals. The 4DCT datasets were
sorted into 10 images (0%-90%) by Advantage 4D soft-
ware (GE Medical Systems).
Measurements of EM and NM
The 4DCT datasets were transferred to the Pinnacle3
treatment planning system, version 9.6 (Philips Medical
Systems, Andover, MA). We used images at 2 respiratory
phases (0% and 50%) to measure the EM and NM. The
0% image represented the end of inhalation; the 50%
image represented the end of exhalation. The methods
that we used to measure the centroid motion are indicated
in Fig 1A. For the EM measurements, the adventitia of the
esophagus was contoured from the cricoid bone (inlet of
the esophagus) to the esophagogastric junction in the 2
selected images by 1 radiation oncologist and 1 medical
physicist. All esophageal contours were divided at the
carina. The centroid points were set to the esophagus
above the carina and below the carina in the 0% and 50%
images, respectively. The EM was measured in the left-
right (LR), anteroposterior (AP), and SI directions by
the difference between the centroid points of the 0%
image and those of the 50% image. We evaluated each
difference in the EM according to cT stage and primary
tumor location. For the NM measurements, the outlines of
lymph nodal metastasis were contoured in the 0% and
50% images. The NM values at the cervicothoracic and
the abdominal region were also measured from the
centroid motion, respectively. The 95th percentile values
from cumulative distribution were determined in all
directions.
Assessments of the ITV margins
The centroid motion could approximately reﬂect the
ITV margins if a solid tumor is being investigated.
However, the centroid motion would be insufﬁcient to
represent the shape change of the esophagus such as the
expansion and contraction. For this reason, we used
different methods to measure the EM and the ITV mar-
gins. The ITV margins were measured using the ROI
expansion tool of the Pinnacle3. Although the 4DCT-
average images approximately include the information of
internal motion for each patient, those images are still
insufﬁcient to completely delineate the edge of the ITV.
In this study, we deﬁned the ITV margins in each patient
as the maximum distance in each direction from the CTV
at the 4DCT-average images (CTV4Dave) to the inter-
section of the CTV at the 0% and 50% images (ITV0þ50)
of the complete coverage in the Pinnacle3. An example of
Figure 1 (A) The method used to measure the esophageal motion. The centroid points were set to the esophagus above the carina and
below the carina in the 0% phase (the end of inhale) and 50% phase (the end of exhale) images, respectively. The esophageal motion
was measured by the difference between the centroid points of the 0% image and those of the 50% image. (B) The measurement method
used for the internal target volume (ITV) margin. The red lines represent the clinical target volume (CTV) on the 4DCT-average
images (CTV4Dave). The green lines represent the ITV0þ50 (the CTV at the 0% þ the CTV at the 50%). The blue lines represent the
CTV4Dave þ the ITV margins. In this study, we determined the maximum distance in each direction from the CTV4Dave to the ITV0þ50
of the complete coverage as an ITV margin in the Pinnacle3.
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esophagus above and below the carina were deﬁned as the
provisional CTV, respectively. The 95th percentile values
were used to deﬁne the ITV margins for clinical practice
in this study.
Statistical analysis
We used the Kruskal-Wallis test and the Mann-
Whitney U test for statistical analysis in this study.
Values of P < .05 were considered signiﬁcant. All sta-
tistical analyses were performed using SPSS software,
version 22 (Chicago, IL).
Results
The EM characteristics
The EM results for each cT stage are shown in Fig 2A.
There were signiﬁcant differences in the mean EM values
below the carina among cT stages (all directions, P< .01).
The mean EM below the carina in cT4 was signiﬁcantly
smaller than that in cT1-T2 (LR: 0.3 vs 0.9 mm, P < .01;
AP: 0.7 vs 1.7mm,P< .01; SI: 3.0 vs 6.7mm,P< .01) and
than that in cT3 (LR: 0.3 vs 1.0mm,PZ .03; AP: 0.7 vs 2.1
mm, P < .01; SI: 3.0 vs 6.9 mm, P < .01). Because there
was no signiﬁcant difference in the EM between cT1-T2and cT3, we combined the cT1-T2 and cT3 datasets. We
labeled the patient datasets with primary cT4 tumor located
in the esophagus above the carina “cT4/above the carina”
and labeled the patient datasets with primary cT4 tumor
located in the esophagus below the carina “cT4/below the
carina.”
Figure 2B shows the EM results according to primary
tumor location. The signiﬁcant mean EM values in
the comparison of cT1-T3 and cT4/below the carina
(cT4/below the carina vs cT1-T3) were 0.2 versus
0.7 mm in the AP direction (P Z .03) in the esophagus
above the carina, 0.4 versus 1.0 mm in the LR (PZ .03),
0.6 versus 1.9 mm in the AP (P < .01), and 2.2 versus
6.8 mm in the SI (P < .01) in the esophagus below the
carina. The mean EM values below the carina in cT1-T3
and cT4/above the carina (cT4/above the carina vs
cT1-T3) were 0.2 versus 1.0 mm in the LR (P < .01), 1.0
versus 1.9 mm in the AP (P Z .04), and 4.5 versus 6.8
mm in the SI (P Z .05). We also found that on the CT
images, the EM in cT4/below the carina was much
smaller than that in cT1-T3 (Fig 3). The mean EM below
the carina in cT4/below the carina was signiﬁcantly
smaller than that in cT4/above the carina (SI: 2.2 vs
4.5 mm, P < .01). The details of the mean and the 95th
percentile values of the EM are summarized in Table 2.
From these results, we found that the EM including
respiratory and other random motion differs according to
cT stage and primary tumor location.
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Figure 2 (A) The esophageal motion characteristics according to cT stage (cT1-T2 in blue, cT3 in green, cT4 in red). (B) Comparison
of the esophageal motion according to primary tumor location (cT1-T3 in blue, cT4/above the carina in orange, cT4/below the carina in
red). cT4/above the carina, the datasets of patients with primary cT4 tumor located in the esophagus above the carina; cT4/below the
carina, the datasets of patients with primary cT4 tumor located in the esophagus below the carina.
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The NM results are also summarized in Table 2. The
mean NM at the abdominal region in all directions was
signiﬁcantly more mobile than that at the cervicothoracic
region (LR: 0.7 vs 1.5 mm, PZ .04; AP: 0.6 vs 5.0 mm,
P < .01; SI: 1.2 vs 8.6 mm, P < .01). The mean NM at
the abdominal region was also signiﬁcantly larger than the
mean EM below the carina in cT1-T3 (AP: 1.9 vs 5.0 mm,
P < .01), the cT4/above the carina (LR: 0.2 vs 1.5 mm,
P < .01; AP: 1.0 vs 5.0 mm, P < .01; SI: 4.5 vs 8.6 mm,
P < .01), and the cT4/below the carina (LR: 0.4 vs
1.5 mm, PZ .01; AP: 0.6 vs 5.0 mm, P < .01; SI: 2.2 vs
8.6 mm, P < .01).
Assessments of the ITV margins
The mean and the 95th percentile values of the ITV
margins are summarized in Table 3. The ITV margins in
cT4/below the carina were signiﬁcantly smaller than those
in cT1-T3 (above and below the carina, all directions:P < .01). The ITV margins in cT4/above the carina were
smaller than those in cT1-T3 (above the carina; SI:
P< .01). Much larger ITVmargins were necessary for LNs
at the abdominal region compared with those for LNs at the
cervicothoracic region and for the esophagus below the
carina.
Discussion
To our knowledge, this is the ﬁrst study to report the
EM characteristics and the ITV margins for the esophagus
according to cT stage and primary tumor location in
esophageal cancer. In the comparison of our results with
those of previous studies, the EM and the ITV margins in
our cT1-T3 cases were similar to or slightly smaller than
those studies’ values, and those in our cT4 cases were
much less than the reported values. Most of the previous
studies quantiﬁed the motion and the ITV margins for
esophageal cancer investigated only in primary solid
tumor. In clinical RT planning for advanced esophageal
cancer, however, we need to include the partial esophagus
Figure 3 Example of the esophageal motion (EM) comparisons between cT1-T3 and cT4/below the carina (primary cT4 tumor
located in the esophagus below the carina). These axial CT images are at the abdominal level. The clinical target volumes are repre-
sented in red lines (at the 0% phase) and blue lines (at the 50% phase).
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Cohen et al7 found that the mean absolute values of the
inter-/intrafractional esophageal motion was 4.2 mm or
less using CT-on-rails imaging in patients with thoracic
esophageal cancer.
There are several studies that investigate the esoph-
ageal tumor motion using 4DCT. Yaremko et al10 re-
ported that the mean tumor motion at the distal
esophagus using 4DCT in the LR, AP, and SI directions
were 1.3 mm, 2.3 mm, and 7.1 mm, respectively. Patel
et al11 reported that the mean esophageal tumor motion
in the LR, AP, and SI directions were 2.2 mm, 2.8 mm,
and 8.0 mm, respectively. In the present study, the mean
EM values below the carina in cT1-T3 (LR: 1.0 mm,Table 2 The esophageal and lymph nodal motion
Esophageal motion Above the carina (mm)
Mean SD 95th pe
cT1-T3
LR 0.3 0.3 0.8
AP 0.7 0.7 1.4
SI 1.9 1.5 4.2
cT4/above the carina
LR 0.3 0.3 0.6
AP 0.5 0.3 0.8
SI 1.2 0.8 2.2
cT4/below the carina
LR 0.1 0.2 0.5
AP 0.2 0.2 0.6
SI 1.1 0.9 2.3
Nodal motion Cervicothoracic region (mm)
Mean SD 95th perce
LR 0.7 0.6 1.6
AP 0.6 0.5 1.3
SI 1.2 0.9 2.4
AP, anteroposterior; cT4/above the carina, the datasets of patients with prima
carina, the datasets of patients with primary cT4 tumor located in the esop
superoinferior.AP: 1.9 mm, SI: 6.8 mm) were almost the same as the
values of these previous studies. Jin et al14 also reported
tumor motion using ﬁducial markers and 4DCT in
esophageal cancer. They recommended the setting
region-dependent ITV margins. In addition to this effect
of tumor region, our present ﬁndings newly indicated
that cT stage inﬂuences the EM.
Signiﬁcant variations in the EM according to cT stage
and primary tumor location were revealed in the present
study. We found that the EM below the carina in cT4 was
signiﬁcantly smaller compared with that in cT1-T3. In
cT4/below the carina, the EM below the carina was more
reduced than that in cT4/above the carina. We suspect that
the cause of the EM reduction in cT4 cases is the adhesionBelow the carina (mm)
rcentile Mean SD 95th percentile
1.0 0.7 2.4
1.9 1.2 4.0
6.8 2.8 11.1
0.2 0.2 0.5
1.0 0.7 1.9
4.5 1.4 6.1
0.4 0.3 0.8
0.6 0.3 1.0
2.2 0.9 3.4
Abdominal region (mm)
ntile Mean SD 95th percentile
1.5 1.2 3.5
5.0 2.7 8.9
8.6 3.3 14.2
ry cT4 tumor located in the esophagus above the carina; cT4/below the
hagus below the carina; LR, left to right; SD, standard deviation; SI,
Table 3 The ITV margins for the esophagus and lymph nodes
Esophagus Above the carina (mm) Below the carina (mm)
Mean SD 95th percentile Mean SD 95th percentile
cT1-T3
LR 2.4 0.5 3.0 4.9 0.9 6.0
AP 2.3 0.6 3.0 5.1 1.0 6.2
SI 3.4 1.2 5.0 7.0 3.2 12.8
cT4/above the carina
LR 1.8 0.4 2.0 4.4 0.9 5.0
AP 1.8 0.4 2.0 4.6 1.1 5.8
SI 1.0 1.4 2.5 7.5 1.8 9.5
cT4/below the carina
LR 1.6 0.5 2.0 2.7 0.7 3.6
AP 1.3 0.5 2.0 2.7 0.8 3.8
SI 0.6 1.1 2.5 3.1 1.7 5.0
Lymph nodes Cervicothoracic region (mm) Abdominal region (mm)
Mean SD 95th percentile Mean SD 95th percentile
LR 1.8 0.4 2.0 4.1 1.5 5.6
AP 1.8 0.4 2.0 5.6 3.1 9.2
SI 1.7 1.2 2.5 9.0 4.3 15.0
cT4/above the carina, the datasets of patients with primary cT4 tumor located in the esophagus above the carina; cT4/below the carina, the datasets of
patients with primary cT4 tumor located in the esophagus below the carina; ITV, internal target volume; SD, standard deviation.
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to our ﬁndings, Yu et al19 also indicated that lung tumor
motion of locally advanced-stage cancer was smaller than
that of early-stage cancer. In this study, the EM above the
carina was much smaller in comparison to that below the
carina. An earlier investigation also showed that regarding
primary tumors, the motion in lower locations was larger
than that in upper locations.13,14 There was no meaningful
difference because of cT stage in the EM above the carina
in the present study.
Several studies reported the ITV margins for primary
esophageal tumor. Qiu et al15 evaluated the displacement
differences of markers between proximal and distal ends of
tumor and investigated whether the ITV margins should be
determined separately in patients with mid-upper thoracic
ESCC. The ITVmargins that covered 95% of their datasets
in the LR, AP, and SI directions were 2.9, 2.4, and 5.0 mm,
respectively. These values were the same as the ITV above
the carina in cT1-T3 cases in our study. Patel et al11 also
indicated that the ITV margins for esophageal primary
tumors were 7.5 mm (LR), 7.5 mm (AP), and 15.0 mm
(SI), respectively. Their ITV margins were greater than
those in the present study, especially in cT4.
The ITV margins for the esophagus should be changed
according to cT stage and primary tumor location. The
ITV margins with 95% coverage in our datasets in each
case were: in cT1-T3, the ITV margins in the LR, AP, and
SI directions were 3.0 mm, 3.0 mm, and 5.0 mm for the
esophagus above the carina, and 6.0 mm, 6.2 mm,
and 12.8 mm for the esophagus below the carina; in cT4/
above the carina, the ITV margins in the LR, AP, and SIdirections were 2.0 mm, 2.0 mm, and 2.5 mm for the
esophagus above the carina, and 5.0 mm, 5.8 mm, and 9.5
mm for the esophagus below the carina; in cT4/below the
carina, the ITV margins in the LR, AP, and SI directions
were 2.0 mm, 2.0 mm, and 2.5 mm for the esophagus
above the carina, and 3.6 mm, 3.8 mm, and 5.0 mm for
the esophagus below the carina.
Our study indicated that the ITV margins for cT4 cases
could be set smaller than those in cT1-T3 cases. If the
generalized ITV margins are determined independently
from clinical factors such as cT stage and tumor location,
we must be careful to avoid excessive ITV margins. By
using the ITV margins (ie, LR: 3.6 mm; AP: 3.8 mm; SI:
5.0 mm; Table 3) for cT4 patients treated with deﬁnitive
CRT, radiation toxicities such as radiation pneumonitis
and pericarditis would be reduced.
Previous studies indicated that the esophageal tumor
motion is variable according to several factors such as the
region of the esophagus or the direction of motion.10-16 In
addition to these factors, our present ﬁndings revealed that
cT stage also inﬂuenced the esophageal motion and the
ITV margin in esophageal cancer. If the patient-speciﬁc
ITV is to be used, the ITV margin should be deter-
mined using the several 4D phase images of each patient.
Chen et al16 recommended that the ITV should be created
from the three phase images (0%, 50%, and 80%; the
middle of the inhalation) to account for regular breathers
or 4-phase images (0%, 50%, 60%, and 80%) to adjust for
irregular breathers. Compared with their method, the ITV
determination in the present study (CTV at 4D average þ
deﬁned ITV margin for each cT stage) enabled us to
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guide margins in future clinical trials at any institution, as
a safe and generalized ITV margin for each cT stage.
NM information is an important factor for the deter-
mination of clinical ITV margins for esophageal cancer.
Patel et al11 demonstrated that the mean NM of the celiac
region in the LR, AP, and SI directions were 1.9 mm, 4.6
mm, and 9.2 mm, respectively. They used the datasets of
metastatic LNs diagnosed by not only pathological ex-
amination but also PET-positive images; the present study
is the ﬁrst to investigate the NM using only datasets with
pathological conﬁrmation. The mean NM values at the
abdominal region observed in the present study were 1.5
mm (LR), 5.0 mm (AP), and 8.6 mm (SI), and these
values are almost the same as those reported by Patel
et al.11 In the present study, the NM at the cervicothoracic
region in all directions was much smaller than that at the
abdominal region.
The ITVmargins for the LNs in our dataset were 2.0mm
(LR), 2.0 mm (AP), and 2.5 mm (SI) at the cervicothoracic
region, and 5.6mm (LR), 9.2mm (AP), and 15.0mm (SI) at
the abdominal region. If we determine the RT ﬁelds for
elective lymphatic irradiation, these critical values
regarding the ITV margins should be considered. If the
esophageal ITV margins are applied for LNs at the
abdominal region, the irradiated dose to the involved LNs
would be insufﬁcient to cover the essential area. Patel et al11
also reported that the ITV margins for the celiac-region
lymph nodes were larger than those for esophageal tumor.
Our study has several limitations. We could not assess
random motion including cardiac and peristaltic motion
by using 4DCT. Delineation errors may occur due to the
uncertainty of 4DCT images. Although we found the
tendencies of the EM and ITV margins characteristics
according to cT stage and primary tumor location, the
study’s limited sample size made it difﬁcult to provide a
recommendation of exact values.
Conclusions
Both the EM and the ITV margins in cT4 were signif-
icantly smaller than those in cT1eT3. In cT4/below the
carina, these values were more reduced than those in cT4/
above the carina. In clinical RT planning for esophageal
cancer, cT stage should be taken into consideration. If
smaller ITV margins can be used for cT4 cases than those
generally used, radiation toxicities induced by deﬁnitive
CRT would be reduced. The NM and the ITV margins at
the abdominal region would be larger than those at the
cervicothoracic region and the esophagus below the carina.
References
1. Hashimoto T, Shirato H, Kato M, et al. Real-time monitoring of a
digestive tract marker to reduce adverse effects of moving organs atrisk (OAR) in radiotherapy for thoracic and abdominal tumors. Int J
Radiat Oncol Biol Phys. 2005;61:1559-1564.
2. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation
Therapy Oncology Group 94-05) phase III trial of combined-
modality therapy for esophageal cancer: High-dose versus
standard-dose radiation therapy. J Clin Oncol. 2002;20:1167-1174.
3. Choi N, Park SD, Lynch T, et al. Twice-daily radiotherapy as
concurrent boost technique during two chemotherapy cycles in
neoadjuvant chemoradiotherapy for resectable esophageal carci-
noma: Mature results of phase II study. Int J Radiat Oncol Biol
Phys. 2004;60:111-122.
4. Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after
deﬁnitive chemoradiotherapy for squamous cell carcinoma of the
thoracic esophagus. J Clin Oncol. 2003;21:2697-2702.
5. Shields TW, Locicero TW, Ponn RB, et al. General Thoracic Sur-
gery. 6th ed. 2. Philadelphia: Lippincott Williams & Wilkins; 2005:
1894-1895.
6. Gao X-ss, Qiao X, Wu F, et al. Pathological analysis of clinical
target volume margin for radiotherapy in patients with esophageal
and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol
Phys. 2007;67:389-396.
7. Cohen RJ, Paskalev K, Litwin S, et al. Esophageal motion during
radiotherapy: Quantiﬁcation and margin implications. Dis Esoph-
agus. 2010;23:473-479.
8. International Commission on Radiation Units and Measurements.
ICRU report 62. Prescribing, recording and reporting photon beam
therapy. Supplement to ICRU report 50. Bethesda, MD: ICRU; 1999.
9. Moorrees J, Bezak E. Four dimensional radiotherapy: A review of
current technologies and modalities. Australas Phys Eng Sci Med.
2012;35:399-406.
10. Yaremko BP, Guerrero TM, McAleer MF, et al. Determination of
respiratory motion for distal esophagus cancer using four-
dimensional computed tomography. Int J Radiat Oncol Biol Phys.
2008;70:145-153.
11. Patel AA, Wolfgang JA, Niemierko A, et al. Implications of respi-
ratory motion as measured by four-dimensional computed tomog-
raphy for radiation treatment planning of esophageal cancer. Int J
Radiat Oncol Biol Phys. 2009;74:290-296.
12. WangW,Li JB, ZhangY, et al. Comparison of patient-speciﬁc internal
gross tumor volume for radiation treatment of primary esophageal
cancer based separately on three-dimensional and four-dimensional
computed tomography images. Dis Esophagus. 2014;27:348-354.
13. Yamashita H, Kida S, Sakumi A, et al. Four-dimensional mea-
surement of the displacement of internal ﬁducial markers during
320-multislice computed tomography scanning of thoracic esopha-
geal cancer. Int J Radiat Oncol Biol Phys. 2011;79:588-595.
14. Jin P, Hulshof M, Jong R, et al. Quantiﬁcation of respiration-induced
esophageal tumor motion using ﬁducial markers and four-dimensional
computed tomography. Radiother Oncol. 2016;118:492-497.
15. Qiu G, Wen D, DU X, et al. Differences in displacement of the
proximal and distal ends of mid-upper thoracic esophageal squa-
mous cell carcinoma. Mol Clin Oncol. 2016;5:143-147.
16. Chen X, Lu H, Tai A, et al. Determination of internal target volume
for radiation treatment planning of esophageal cancer by using 4-
dimensional computed tomography (4DCT). Int J Radiat Oncol Biol
Phys. 2014;90:102-109.
17. Yuan S, Yu Y, Chao KS, et al. Additional value of PET/CT over
PET in assessment of locoregional lymph nodes in thoracic esoph-
ageal squamous cell cancer. J Nucl Med. 2006;47:1255-1259.
18. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an
independent prognostic parameter in esophageal cancer: Lessons
from more than 1,000 consecutive resections at a single center in the
Western world. Ann Surg. 2001;234:360-367.
19. Yu ZH, Lin SH, Balter P, et al. A comparison of tumor motion
characteristics between early stage and locally advanced stage lung
cancers. Radiother Oncol. 2012;104:33-38.
